Lyophilized Injectable Market Forecast to 2028

Report Code : TIPRE00004411 | Region : Global | Industry : Pharmaceuticals | Published Date : 10/Aug/2022
Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)

The global lyophilized injectable market is projected to reach US$ 4,001.27 million by 2028 from US$ 2,719.42 million in 2021; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.

The increasing demand for contract research manufacturing services, rising approvals of pharmaceuticals, and growing demand for biologics drive the growth of the market. However, high product recalls hamper the market growth.

Freeze drying, or lyophilization, consists of the sublimation of ice crystals into vapor. Lyophilization is a process based on negative temperatures, the product's activity, and stability, along with active ingredients that are retained while limiting any damage to the product and avoiding any degradation of the molecules. Thus, freeze-drying is especially popular in the pharmaceutical & diagnostic sectors. The increased quality and extended shelf life of lyophilized injectable drugs created growth opportunities for manufacturers to implement the lyophilization process in product manufacturing. The contract manufacturing and research services are in huge demand, delivering lyophilized injectable drugs to offer high-quality products to the end users.

Moreover, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, which is propelling the demand for contract research manufacturing services (CRAMs) for manufacturing. Furthermore, CRAMs play crucial roles to mitigate the risk of supply shortages by offering additional sites for pharmaceutical companies with multisite supply strategies and backup capacities. For instance, in 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under the agreement, Samsung Biologics provided services ranging from the development of cell line to the production of Phase I drug substances.

Furthermore, the advantages offered by the lyophilized injectables, such as safe transit and extended pharmaceutical storage life, increased the adoption of the lyophilization technique by many enterprises globally.

The global impacts of COVID-19 pandemic are witnessed across several markets. Due to stringent lockdown and movement restrictions, clinical trials were temporarily halted. In the healthcare sector, the focus was shifted primarily to the treatment of COVID-19 patients and the development of the COVID-19 vaccine. All these factors had a positive impact on market growth in the initial phase of pandemic.

There was an unusual demand for Remdesivir, an antiviral medicine used to treat patients, during the peak of the COVID-19 outbreak. Manufacturers in the lyophilized injectables market are preparing for the future by keeping adequate supply chains to avoid any COVID-19-like vulnerabilities. Gilead Sciences and other big pharma companies received an Emergency Use Authorization (EUA) by the US FDA for the use of remdesivir for the treatment of hospitalized COVID-19 patients. Further, in May 2020, Gilead Sciences Inc. extended a voluntary nonexclusive license to Cipla to manufacture and market Cipla’s generic version of remdesivir called CIPREMI. Companies are utilizing government programs and financing schemes given by the BFSI industry to streamline their operations in response to turbulent market conditions. For instance, in May 2020, the US government entered an agreement with a group of American generic medicine manufacturers potentially worth US$ 812 million to bolster the country's drug supply amid the pandemic. Thus, the growing demand for drugs due to the COVID-19 pandemic bolstered the global lyophilized injectable market.

Geography-Based Insights

North America holds the largest share of the global lyophilized injectable market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the increasing demand for lyophilized injectables for safe packaging and prolonged shelf life, growing pharmaceutical production due to the COVID-19 pandemic, and rising research and development in the healthcare industry.

During 2022–2028, Asia Pacific is likely to register the highest CAGR in the global lyophilized injectable market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The growing research & development activities due to the increase in the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and rising applications of lyophilized injectable drug in various fields are among the factors propelling the demand for lyophilized injectables in Asia Pacific.

Type of Packaging- Based Insights

The global lyophilized injectable market, based on type of packaging, is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. In 2021, the single-use vials segment accounted for the largest market share, whereas the specialty packaging segment is expected to register the highest CAGR of 6.7% during the forecast period.

Type of Delivery- Based Insights

Based on type of delivery, the global lyophilized injectable market is segmented into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.3% during the forecast period.

Indication- Based Insights

Based on indication, the global lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and other indications. The metabolic and oncology conditions segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.2% during the forecast period.

End User- Based Insights

Based on end user, the global lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2021. However, the specialty clinics segment is estimated to register the highest CAGR of 6.3% in the market during the forecast period.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Association for the Advancement of Medical Instrumentation are a few secondary sources referred to while preparing the report on the global lyophilized injectable market.

The List of Companies - Lyophilized Injectable Drugs Market

1. Baxter

2. Nipro

3. Curia Global, Inc.

4. Recipharm AB

5. Vetter Pharma

6. Jubilant HollisterStier LLC (Jubilant Pharma Limited)

7. Aristopharma Ltd.

8. CordenPharma International

9. Credence MedSystems, Inc.

10. S. G. Biopharm Pvt. Ltd

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Lyophilized Injectable Market – By Type of Packaging

1.3.2 Global Lyophilized Injectable Market – By Type of Delivery

1.3.3 Global Lyophilized Injectable Market – By Indication

1.3.4 Global Lyophilized Injectable Market – By End User

1.3.5 Global Lyophilized Injectable Market – By Geography

2. Lyophilized Injectable Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Lyophilized Injectable Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Experts Opinion

5. Lyophilized Injectable Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Demand for Contract Research Manufacturing Services

5.1.2 Rising Approvals of Pharmaceuticals

5.1.3 Increasing Demand of Biologics

5.2 Market Restraints

5.2.1 Product Recalls

5.3 Market Opportunities

5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs

5.4 Future Trends

5.4.1 Advancement in Lyophilized Packaging

5.5 Impact Analysis

6. Lyophilized Injectable Market– Global Analysis

6.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis

6.1.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis

6.1.2 Global Lyophilized Injectable Market – Market Potential Analysis, by Region

6.2 Comparative Company Analysis

6.3 Growth Strategy Analysis

6.4 Market Positioning Analysis of Key Players in Lyophilized Injectable Market

6.5 Performance of Key Players

6.5.1.1 Baxter International

6.5.1.2 Nipro

6.6 Market Share Analysis

6.7 Top 3 Lyophilized Drug Products (ASP) (2021)

7. Lyophilized Injectable Market Analysis – By Type of Packaging

7.1 Overview

7.2 Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

7.3 Single-use vials

7.3.1 Overview

7.3.2 Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Point-of-Care Reconstitution

7.4.1 Overview

7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Specialty Packaging

7.5.1 Overview

7.5.2 Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8. Lyophilized Injectable Market Analysis – By Type Of Delivery

8.1 Overview

8.2 Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

8.3 Prefilled Diluent Syringes

8.3.1 Overview

8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Single Step Devices

8.4.1 Overview

8.4.2 Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Proprietary Reconstitution Devices

8.5.1 Overview

8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Multi-Step Devices

8.6.1 Overview

8.6.2 Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9. Lyophilized Injectable Market Analysis – By Indication

9.1 Overview

9.2 Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

9.3 Metabolic and Oncology Conditions

9.3.1 Overview

9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Infectious Diseases

9.4.1 Overview

9.4.2 Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Autoimmune Diseases

9.5.1 Overview

9.5.2 Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Other Indications

9.6.1 Overview

9.6.2 Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10. Lyophilized Injectable Market –By End User

10.1 Overview

10.2 Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Specialty Clinics

10.5.1 Overview

10.5.2 Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Other End Users

10.6.1 Overview

10.6.2 Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11. Lyophilized Injectable Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1 North America: Lyophilized Injectable Market

11.1.1 Overview

11.1.2 North America: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3 North America: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.4 North America: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.5 North America: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.6 North America: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.1.7 North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.1.7.1 US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1 Overview

11.1.7.1.2 US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3 US: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.7.1.4 US: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.7.1.5 US: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.7.1.6 US: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.1.7.2 Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1 Overview

11.1.7.2.2 Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3 Canada: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.7.2.4 Canada: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.7.2.5 Canada: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.7.2.6 Canada: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.1.7.3 Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1 Overview

11.1.7.3.2 Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3 Mexico: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.7.3.4 Mexico: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.7.3.5 Mexico: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.7.3.6 Mexico: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.2 Europe: Lyophilized Injectable Market

11.2.1 Overview

11.2.2 Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.3 Europe: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.4 Europe: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.5 Europe: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.6 Europe: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.2.7 Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.2.7.1 Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.1.1 Overview

11.2.7.1.1 Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.1.2 Germany: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.7.1.3 Germany: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.7.1.4 Germany: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.7.1.5 Germany: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.2.7.2 UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.2.1 Overview

11.2.7.2.2 UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.2.3 UK: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.7.2.4 UK: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.7.2.5 UK: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.7.2.6 UK: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.2.7.3 France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.3.1 Overview

11.2.7.3.2 France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.3.3 France: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.7.3.4 France: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.7.3.5 France: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.7.3.6 France: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.2.7.4 Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.4.1 Overview

11.2.7.4.2 Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.4.3 Italy: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.7.4.4 Italy: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.7.4.5 Italy: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.7.4.6 Italy: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.2.7.5 Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.5.1 Overview

11.2.7.5.2 Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.5.3 Spain: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.7.5.4 Spain: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.7.5.5 Spain: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.7.5.6 Spain: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.2.7.6 Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.6.1 Overview

11.2.7.6.2 Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.2.7.6.3 Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.2.7.6.4 Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.2.7.6.5 Rest of Europe: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.2.7.6.6 Rest of Europe: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.3 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts To 2028

11.3.1 Overview

11.3.2 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.3 Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.4 Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.5 Asia Pacific: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.6 Asia Pacific: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.3.7 Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.3.7.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.1.1 Overview

11.3.7.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.7.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.7.1.5 China: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.7.1.6 China: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.3.7.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.2.1 Overview

11.3.7.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.7.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.7.2.5 India: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.7.2.6 India: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.3.7.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.3.1 Overview

11.3.7.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.7.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.7.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.7.3.6 Japan: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.3.7.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.4.1 Overview

11.3.7.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.7.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.7.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.7.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.3.7.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.5.1 Overview

11.3.7.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.7.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.7.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.7.5.6 Australia: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.3.7.6 Rest of Asia Pacific: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.3.7.6.1 Overview

11.3.7.6.2 Rest of Asia Pacific: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.3.7.6.3 Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

11.3.7.6.4 Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.3.7.6.5 Rest of Asia Pacific: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.3.7.6.6 Rest of Asia Pacific: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.4 South and Central America Lyophilized Injectable Market

11.4.1 Overview

11.4.2 South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

11.4.3 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)

11.4.4 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)

11.4.5 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)

11.4.6 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)

11.4.7 South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.4.7.1 Brazil: Lyophilized Injectable Market – Revenue and Forecast to 2028 (USD Million)

11.4.7.1.1 Overview

11.4.7.1.2 Brazil Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

11.4.7.1.3 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)

11.4.7.1.4 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)

11.4.7.1.5 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)

11.4.7.1.6 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)

11.4.7.2 Argentina: Lyophilized Injectable Market – Revenue and Forecast to 2028 (USD Million)

11.4.7.2.1 Overview

11.4.7.2.2 Argentina Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

11.4.7.2.3 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)

11.4.7.2.4 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)

11.4.7.2.5 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)

11.4.7.2.6 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)

11.4.7.3 Rest of the South and Central America: Lyophilized Injectable Market – Revenue and Forecast to 2028 (USD Million)

11.4.7.3.1 Overview

11.4.7.3.2 Rest of the South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

11.4.7.3.3 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)

11.4.7.3.4 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)

11.4.7.3.5 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)

11.4.7.3.6 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)

11.5 Middle East & Africa Lyophilized Injectable Market Revenue and Forecasts To 2028

11.5.1 Overview

11.5.2 Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.3 Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.5.4 Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.5.5 Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.5.6 Middle East and Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.5.7 Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.5.7.1 South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.1.1 Overview

11.5.7.1.2 South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.1.3 South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.5.7.1.4 South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.5.7.1.5 South Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.5.7.1.6 South Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.5.7.2 Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.2.1 Overview

11.5.7.2.2 Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.2.3 Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.5.7.2.4 Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.5.7.2.5 Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.5.7.2.6 Saudi Arabia: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.5.7.3 UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.3.1 Overview

11.5.7.3.2 UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.3.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.5.7.3.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.5.7.3.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.5.7.3.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.5.7.4 Rest of Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.4.1 Overview

11.5.7.4.2 Rest of Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.5.7.4.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.5.7.4.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.5.7.4.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.5.7.4.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

12. Impact of COVID-19 Pandemic on Global Lyophilized Injectable Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 South and Central America: Impact Assessment of COVID-19 Pandemic

12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Lyophilized Injectable Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Lyophilized Injectable Market

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Baxter

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Nipro

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Curia Global, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Recipharm AB

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Vetter Pharma

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Jubilant HollisterStier (Jubilant Pharma Limited)

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Aristopharma Ltd.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 CordenPharma International

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Credence MedSystems, Inc.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 S.G. Biopharm Pvt. Ltd.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1. Top 3 Lyophilized Drug Products ((Global Average Selling Price (ASP)) (2021)

Table 2. North America Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 18. Europe: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 19. Europe: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 20. Europe: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 21. Europe: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 22. Germany: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 23. Germany: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 24. Germany: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 25. Germany: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 26. UK: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 27. UK: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 28. UK: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 29. UK: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 30. France: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 31. France: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 32. France: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 33. France: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 34. Italy: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 35. Italy: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 36. Italy: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 37. Italy: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 38. Spain: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 39. Spain: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 40. Spain: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 41. Spain: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 42. Rest of Europe: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 43. Rest of Europe: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 44. Rest of Europe: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 45. Rest of Europe: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 46. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million).

Table 47. Asia Pacific: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 48. Asia Pacific: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 49. Asia Pacific: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 50. China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

Table 51. China: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 52. China: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 53. China: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 54. India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

Table 55. India: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 56. India: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 57. India: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 58. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

Table 59. Japan: Lyophilized Injectable Market, by Type of Delivery– Revenue and Forecast to 2028 (US$ Million)

Table 60. Japan: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 61. Japan: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 62. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

Table 63. South Korea: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 64. South Korea: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 65. South Korea: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 66. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

Table 67. Australia: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 68. Australia: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 69. Australia: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 70. Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)

Table 71. Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 72. Rest of Asia Pacific: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 73. Rest of Asia Pacific: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 74. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)

Table 75. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)

Table 76. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)

Table 77. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 78. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)

Table 79. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)

Table 80. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)

Table 81. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 82. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)

Table 83. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)

Table 84. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)

Table 85. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 86. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)

Table 87. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)

Table 88. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)

Table 89. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 90. Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 91. Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 92. Middle East and Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 93. Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 94. South Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 ( US$ ‘Million)

Table 95. South Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 96. South Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 97. South Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 98. Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 99. Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 100. Saudi Arabia: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 101. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 102. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 103. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 104. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 105. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 106. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 107. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 108. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 109. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 110. Recent Inorganic Growth Strategies in the Lyophilized Injectable Market

Table 111. Recent Organic Growth Strategies in the Lyophilized Injectable Market

Table 112. Glossary of Terms, Lyophilized Injectable Market

The List of Companies - Lyophilized Injectable Drugs Market

1. Baxter

2. Nipro

3. Curia Global, Inc.

4. Recipharm AB

5. Vetter Pharma

6. Jubilant HollisterStier LLC (Jubilant Pharma Limited)

7. Aristopharma Ltd.

8. CordenPharma International

9. Credence MedSystems, Inc.

10. S. G. Biopharm Pvt. Ltd

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the lyophilized injectable market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the lyophilized injectable market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Lyophilized Injectable Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry